News

Social inhibition stings rosacea patients


 

The phymatous form of rosacea (subtype 3) has the most profound negative effect on patients’ social lives, compared with other subtypes, according to a survey by the National Rosacea Society.

More than 82% of those surveyed said that they had experienced erythematotelangiectatic rosacea (subtype 1), compared with 66.5% reporting symptoms of papulopustular (subtype 2), 16.4% reporting phymatous (subtype 3), and 41.6% reporting ocular (subtype 4) rosacea, the society said.

Overall, about 70% of respondents said that their rosacea had inhibited their social lives. The most common complaint, cited by almost 50% of patients, was having to refuse food or drink for fear of triggering a flare-up.

When analyzed by subtype, those patients with subtype 3 were most likely (85%) to have their social lives negatively affected. Those with subtype 2 were the next most likely to be negatively affected (77%), followed by subtype 4 (71%) and subtype 1 (61%), according to the survey data.

However, approximately two-thirds (62%) of the respondents said that medical therapy had at least somewhat reduced the negative impact of rosacea on their social lives.

rfranki@frontlinemedcom.com

Recommended Reading

Pooled data allow fine-tuning of surveillance intervals for AAA
MDedge Internal Medicine
Aspirin may protect older women from melanoma
MDedge Internal Medicine
Systemic steroid prescriptions for psoriasis persist
MDedge Internal Medicine
Screen all psoriasis patients for hepatitis before immunosuppressive therapy
MDedge Internal Medicine
Plantar wart therapy smackdown: Cryotherapy vs. salicylic acid
MDedge Internal Medicine
Eat fish and avoid acne?
MDedge Internal Medicine
Ipilimumab plus surgery boosted advanced melanoma survival
MDedge Internal Medicine
One in four melanoma patients shun sunscreen
MDedge Internal Medicine
Are dermatologists falling behind the technology curve?
MDedge Internal Medicine
Melanoma increases in adolescents
MDedge Internal Medicine